KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
-11.67%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$308M
AUM Growth
+$308M
(+64%)
Cap. Flow
+$134M
Cap. Flow
% of AUM
43.61%
Top 10 Holdings %
Top 10 Hldgs %
76.32%
Holding
36
New
3
Increased
13
Reduced
15
Closed
2
Top Buys
| 1 |
Natera
NTRA
|
$39.3M |
| 2 |
Celldex Therapeutics
CLDX
|
$17.9M |
| 3 |
Travere Therapeutics
TVTX
|
$17.8M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$17M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$12M |
Top Sells
| 1 |
Xenon Pharmaceuticals
XENE
|
$5.71M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$3.34M |
| 3 |
Liquidia Corp
LQDA
|
$1.49M |
| 4 |
Cogent Biosciences
COGT
|
$1.29M |
| 5 |
Krystal Biotech
KRYS
|
$1.09M |
Sector Composition
| 1 | Healthcare | 99.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $46.4M | 15.05% | 1,339,322 +346,373 | +35% | +$12M |
|
|
2
Natera
NTRA
$23.1B
| $39.3M | 12.75% | +966,400 | New | +$39.3M |
|
|
3
Syndax Pharmaceuticals
SNDX
$1.41B
| $33.6M | 10.9% | 1,932,800 +976,635 | +102% | +$17M |
|
|
4
Celldex Therapeutics
CLDX
$1.47B
| $25.6M | 8.32% | 753,034 +526,308 | +232% | +$17.9M |
|
|
5
Travere Therapeutics
TVTX
$1.56B
| $22.4M | 7.28% | 870,918 +688,815 | +378% | +$17.8M |
|
6
Gossamer Bio
GOSS
$562M
| $15.9M | 5.16% | 1,832,704 +815,847 | +80% | +$7.08M |
|
|
7
Xenon Pharmaceuticals
XENE
$2.98B
| $14.8M | 4.79% | 483,270 -186,823 | -28% | -$5.71M |
|
8
Vaxcyte
PCVX
$4B
| $14M | 4.54% | 579,640 +368,157 | +174% | +$8.89M |
|
9
Vera Therapeutics
VERA
$1.38B
| $11.8M | 3.83% | 502,328 +248,879 | +98% | +$5.85M |
|
10
Viridian Therapeutics
VRDN
$1.5B
| $10.9M | 3.54% | 589,826 +301,892 | +105% | +$5.58M |
|
|
11
Liquidia Corp
LQDA
$2.38B
| $8.33M | 2.7% | 1,159,674 -207,162 | -15% | -$1.49M |
|
12
Biogen
BIIB
$19.4B
| $8.05M | 2.61% | 38,236 -1,764 | -4% | -$372K |
|
|
AMRN
13
Amarin Corp
AMRN
$311M
| $7.55M | 2.45% | 2,294,082 +83,216 | +4% | +$274K |
|
|
BNR
14
Burning Rock Biotech
BNR
$93.6M
| $7.18M | 2.33% | 773,114 +390,650 | +102% | +$3.63M |
|
|
SRRA
15
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $6.2M | 2.01% | +193,280 | New | +$6.2M |
|
|
CNTA
16
Centessa Pharmaceuticals
CNTA
$2.25B
| $6M | 1.95% | 669,100 +430,059 | +180% | +$3.86M |
|
17
Amicus Therapeutics
FOLD
$2.34B
| $5.43M | 1.76% | 573,516 -183 | -0% | -$1.73K |
|
18
Wave Life Sciences
WVE
$1.53B
| $3.82M | 1.24% | 1,911,728 +417,134 | +28% | +$834K |
|
19
Fate Therapeutics
FATE
$120M
| $3.54M | 1.15% | 91,337 -4,224 | -4% | -$164K |
|
20
Merus
MRUS
$4.98B
| $3.09M | 1% | 116,764 -5,394 | -4% | -$143K |
|
21
Seres Therapeutics
MCRB
$166M
| $2.08M | 0.67% | 291,443 -13,458 | -4% | -$95.8K |
|
22
Puma Biotechnology
PBYI
$254M
| $1.88M | 0.61% | 653,445 -30,174 | -4% | -$86.9K |
|
|
AKUS
23
DELISTED
Akouos, Inc. Common Stock
AKUS
| $1.84M | 0.6% | 387,892 +288,884 | +292% | +$1.37M |
|
|
RDUS
24
DELISTED
Radius Health, Inc.
RDUS
| $1.64M | 0.53% | 185,514 -8,568 | -4% | -$75.7K |
|
|
AFMD
25
DELISTED
Affimed
AFMD
| $1.52M | 0.49% | 347,965 -16,068 | -4% | -$70.2K |
|